Japan’s Matsushita Develops New DNA Technology For Drug Response
This article was originally published in PharmAsia News
Executive Summary
Matsushita Electric Industrial of Japan reports it has developed a technology that identifies DNA sequence variations electronically for predicting responses to drugs. The system dissolves artificial DNA in a solution instead of attaching it to an electrode, enabling technicians to predict an individual's response to drugs and risk of developing a particular disease. Matsushita refers to the technology as "single nucleotide polymorphisms." (Click here for more